Serum inorganic phosphate level is associated with fibroblast growth factor 23 among cardiac patients with preserved renal function.

Hideaki Morita, Tomohiro Fujisaka, Shu-Ichi Fujita, Nobukazu Ishizaka
Author Information
  1. Hideaki Morita: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
  2. Tomohiro Fujisaka: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
  3. Shu-Ichi Fujita: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
  4. Nobukazu Ishizaka: Departments of Cardiology, Osaka Medical College, Osaka, Japan.

Abstract

No abstract text available.

References

  1. Hypertens Res. 2015 Jan;38(1):74-9 [PMID: 25119474]
  2. Am J Kidney Dis. 2001 Jan;37(1):79-83 [PMID: 11136171]
  3. Nat Rev Endocrinol. 2009 Nov;5(11):611-9 [PMID: 19844248]
  4. PLoS One. 2011;6(12 ):e29105 [PMID: 22220204]
  5. PLoS One. 2016 Jul 11;11(7):e0156860 [PMID: 27400031]
  6. Hypertens Res. 2016 Oct;39(10 ):744-751 [PMID: 27250568]
  7. Kidney Int. 2011 Jun;79(12):1370-8 [PMID: 21389978]
  8. BMC Nephrol. 2014 Sep 08;15:147 [PMID: 25200959]
  9. Hypertens Res. 2017 Feb;40(2):181-188 [PMID: 27682653]

MeSH Term

Fibroblast Growth Factor-23
Fibroblast Growth Factors
Glomerular Filtration Rate
Humans
Phosphates

Chemicals

Phosphates
Fibroblast Growth Factors
Fibroblast Growth Factor-23

Word Cloud

Created with Highcharts 10.0.0Seruminorganicphosphatelevelassociatedfibroblastgrowthfactor23amongcardiacpatientspreservedrenalfunction

Similar Articles

Cited By